Incorporating Immunization Services into Reproductive Health Care

Journal of Midwifery and Women's Health

Volumn 53, Issue 3, 2008, Pages 175-187

  Hackley, Barbara ^a  

^a NONE

Author keywords

immunization; pregnancy; vaccination; vaccine; women

Indexed keywords

CHICKENPOX VACCINE; DIPHTHERIA PERTUSSIS TETANUS VACCINE; HEPATITIS A VACCINE; HEPATITIS B VACCINE; HERPES ZOSTER IMMUNOGLOBULIN; INACTIVATED VACCINE; INFLUENZA VACCINE; LIVE VACCINE; MANACTRA; MEASLES MUMPS RUBELLA VACCINE; MENINGOCOCCUS VACCINE; PNEUMOCOCCUS POLYSACCHARIDE; RECOMBINANT HEPATITIS B VACCINE; THIOMERSAL; VARICELLA ZOSTER VACCINE; WART VIRUS VACCINE;

ANAPHYLAXIS; ARTHRALGIA; ARTHRITIS; ARTHUS PHENOMENON; ARTICLE; BRAIN DISEASE; CHICKENPOX; CLINICAL PRACTICE; CLINICAL PROTOCOL; CLINICAL TRIAL; DIPHTHERIA; DRUG DOSE REGIMEN; DRUG FATALITY; DRUG SAFETY; DRUG USE; EDEMA; GUILLAIN BARRE SYNDROME; GYNECOLOGY; HEALTH SERVICE; HEPATITIS A; HEPATITIS B; HERPES ZOSTER; HUMAN; IMMUNE RESPONSE; IMMUNIZATION; INFECTION PREVENTION; INFLUENZA; LIMB SWELLING; MEASLES; MORBIDITY; MORTALITY; MUMPS; NEURITIS; NEUROLOGIC DISEASE; OBSTETRICS; PERTUSSIS; PREGNANCY; PRIORITY JOURNAL; PUBLIC HEALTH; REPRODUCTIVE HEALTH; RUBELLA; TETANUS; THROMBOCYTOPENIA; UNSPECIFIED SIDE EFFECT; VACCINATION; VERRUCA VULGARIS;

CHICKENPOX; COMMUNICABLE DISEASE CONTROL; COMMUNICABLE DISEASES; EDUCATION, CONTINUING; FEMALE; HERPESVIRUS 3, HUMAN; HUMANS; IMMUNITY, MATERNALLY-ACQUIRED; IMMUNIZATION; IMMUNIZATION PROGRAMS; IMMUNIZATION SCHEDULE; MATERNAL HEALTH SERVICES; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREVENTIVE MEDICINE; TETANUS; UNITED STATES; VACCINES;

EID: 42649120363     PISSN: 15269523     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmwh.2008.01.002     Document Type: Article

References (80)

1. Fedson D. Adult immunization: Summary of the National Vaccine Advisory Committee Report. JAMA 272 (1994) 1133-1137
2. Centers for Disease Control and Prevention, Jajosky R.A., Hall P.A., Adams D.A., Dawkins F.J., Sharp P., et al. Summary of notifiable diseases-United States, 2004. MMWR Morb Mortal Wkly Rep 53 (2006) 1-79
3. World Health Organization Web site, and UNICEF. GIVS Global Immunization Vision and Strategy 2006-2015. www.who.int/vaccines-documents/DocsPDF05/GIVS_Final_EN.pdf [Accessed November 26, 2007]
4. Paul Y. Herd immunity and herd protection. Vaccine 22 (2004) 301-302
5. Jefferson T. Influenza vaccination: Policy versus evidence. BMJ 333 (2006) 912-915
6. Casey J., and Pichichero M. Acellular pertussis vaccine safety and efficacy in children, adolescents, and adults. Drugs 65 (2005) 1367-1389
7. Galazka A., Robertson S., and Oblapenko G. Resurgence of diphtheria. Eur J Epidemiol 11 (1995) 95-105
8. Gangarosa E.J., Galazka A.M., Wolfe C.R., Phillips L.M., Gangarosa R.E., Miller E., et al. Impact of anti-vaccine movements on pertussis control: The untold story. Lancet 351 (1998) 356-361
9. Centers for Disease Control and Prevention. Prevention of varicella: Recommendations of the Advisory Committee on Immunization Practices. MMWR Morb Mortal Wkly Rep 56 (2007) 1-39
10. Centers for Disease Control and Prevention. Varicella-related deaths among adults-United States, 1997. MMWR Morb Mortal Wkly Rep 46 (1997) 409-412
11. Meyer P., Seward J., Jumaan A., and Wharton M. Varicella mortality: Trends before vaccine licensure in the United States, 1970-1994. J Infect Dis 182 (2000) 383-390
12. Centers for Disease Control and Prevention. Prevention of varicella updated recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 48 (1999) 1-5
13. Centers for Disease Control and Prevention. Prevention of varicella: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 45 (1996) 1-25
14. Centers for Disease Control and Prevention. Chartbook on trends in the health of Americans (table 81) (2006), National Center for Health Statistics, Hyattsville, MD. http://www.cdc.gov/nchs/data/hus/hus06.pdf Available from: www.cdc.gov/nchs/data/hus/hus06.pdf [Accessed January 25, 2008]
15. Centers for Disease Control and Prevention. National vaccination coverage among adolescents aged 13-17 years-United States, 2006. MMWR Morb Mortal Wkly Rep 56 (2006) 885-888
16. Lieu T.A., Cochi S.L., Black S.B., Halloran M.E., Shinefield H.R., Holmes S.J., et al. Cost-effectiveness of a routine varicella vaccination program for US children. JAMA 271 (1994) 375-381
17. Gershon A. Live-attenuated varicella vaccine. Infect Dis Clin North Am 15 (2001) 65-81
18. Lopez A., Guris D., Zimmerman L., Gladden L., Moore T., Haselow D., et al. One dose of varicella vaccine does not prevent school outbreaks: Is it time for a second dose?. www.pediatrics.org/cgi/content/full/117/6/e1070 [Accessed October 12, 2007]
19. Brisson M., Edmunds W., and Gay N. Varicella vaccination: Impact of vaccine efficacy on the epidemiology of VZV. J Med Virol 6 (2003) 537-541
20. Arvin A. Varicella-zoster virus. In: Knipe D., Howley P., Griffin D., Lamb R., Martin M., Roizman B., et al. (Eds). Fields virology. 4th ed. (2001), Lippincott Williams & Wilkins, Baltimore 2746-2749
21. MacFarlane L., Sanders M., and Carek P. Concerns regarding universal varicella immunization: Time will tell. Arch Fam Med 6 (1997) 537-541
22. Gershon A. Varicella vaccination: Rare serious problems-But the benefits still outweigh the risks. J Infect Dis 188 (2003) 945-947
23. Schuette M., and Hethcote H. Modeling the effects of varicella vaccination programs on the incidence of chickenpox and shingles. Bull Math Biol 61 (1999) 1031-1064
24. Singarn R., and Benjamin J. Universal vaccination against varicella. N Engl J Med 338 (1998) 683-684
25. Lallier C. Questions about varicella vaccine. Pediatrics 98 (1996) 1226
26. Centers for Disease Control and Prevention. Chartbook on trends in the health of Americans (table 86) (2006), National Center for Health Statistics, Hyattsville, MD. http://www.cdc.gov/nchs/data/hus/hus06.pdf Available from: www.cdc.gov/nchs/data/hus/hus06.pdf [Accessed January 25, 2008]
27. Hambleton S., and Gershon A. The impact of varicella vaccination in the United States. Semin Pediatr Infect Dis 16 (2005) 38-43
28. Welsby P. Chickenpox, chickenpox vaccination, and shingles. Postgrad Med J 82 (2006) 351-352
29. Healy C., and Baker C. Prospects for prevention of childhood infections by maternal immunization. Curr Opin Infect Dis 19 (2006) 271-276
30. Mooi F., and de Greeff S. The case for maternal vaccination against pertussis. Lancet Infect Dis 7 (2007) 614-624
31. Leuridan E., and Van Damme P. Passive transmission and persistence of naturally acquired or vaccine-induced maternal antibodies against measles in newborns. Vaccine 25 (2007) 6296-6304
32. Centers for Disease Control and Prevention Web site, and Advisory Committee on Immunization Practices members. www.cdc.gov/vaccines/recs/acip/members.htm [Accessed October 12, 2007]
33. Centers for Disease Control and Prevention. Recommended adult immunization schedule, United States, October 2007-September 2008. www.cdc.gov/mmwr/preview/mmwrhtml/mm5641a7.htm?s_cid=mm5641a7_e [Accessed October 22, 2007]
34. Centers for Disease Control and Prevention. Preventing tetanus, diphtheria, and pertussis among adults: Use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine. MMWR Morb Mortal Wkly Rep 55 (2006) 1-33
35. Centers for Disease Control and Prevention. Update: Vaccine side effects, adverse reactions, contraindications, and precautions. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 45 (1996) 1-35
36. Centers for Disease Control and Prevention. Measles. In: Atkinson W., Hamborsky J., McIntyre L., and Wolfe S. (Eds). Epidemiology and prevention of vaccine-Preventable diseases. 10th ed. (2007), Public Health Foundation, Washington, DC. http://www.cdc.gov/vaccines/pubs/pinkbook/downloads/meas.pdf Available from: www.cdc.gov/vaccines/pubs/pinkbook/downloads/meas.pdf [Accessed January 10, 2007]
37. Centers for Disease Control and Prevention. Measles, mumps, and rubella-Vaccine use and strategies for elimination of measles, rubella, and congenital rugella syndrome and control of mumps. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 47 (1998) 1-57
38. Black S., Shinefield H., Ray P., Lewis E., Chen R., Glasser J., et al. Risk of hospitalization because of aseptic meningitis after measles-mumps-rubella vaccination in one to two-year old children: An analysis of the Vaccine Safety Datalink (VSD) Project. Pediatr Infect Dis J 16 (1997) 500-503
39. Centers for Disease Control and Prevention. Rubella. In: Atkinson W., Hamborsky J., McIntyre L., and Wolfe S. (Eds). Epidemiology and prevention of vaccine-Preventable diseases. 10th ed. (2007), Public Health Foundation, Washington, DC. http://www.cdc.gov/vaccines/pubs/pinkbook/downloads/rubella.pdf Available from: www.cdc.gov/vaccines/pubs/pinkbook/downloads/rubella.pdf [Accessed January 10, 2007]
40. Sharrar R., LaRussa P., Galea S., Steinberg S., Sweet A., Keatley R., et al. The postmarketing safety profile of varicella vaccination. Vaccine 19 (2000) 916-923
41. Centers for Disease Control and Prevention. Prevention and control of influenza. www.cdc.gov/mmwr/preview/mmwrhtml/rr606a1.htm?s_cid=rr5606a1_e [Accessed October 12, 2007]
42. Haber P., DeStefano F., Angulo F., Shadomy S., Weintraub E., and Chen R. Guillain-Barré syndrome following influenza vaccination. JAMA 92 (2004) 2478-2481
43. Centers for Disease Control and Prevention. Pneumococcal disease. In: Atkinson W., Hamborsky J., McIntyre L., and Wolfe S. (Eds). Epidemiology and prevention of vaccine-Preventable diseases. 10th ed. (2007), Public Health Foundation, Washington, DC. http://www.cdc.gov/vaccines/pubs/pinkbook/downloads/meas.pdf Available from: www.cdc.gov/vaccines/pubs/pinkbook/downloads/meas.pdf [Accessed January 10, 2007].
44. Demicheli V., and Tiberti D. The effectiveness and safety of hepatitis A vaccine: A systematic review. Vaccine 21 (2003) 2242-2245
45. Sepkowitz S. Hair loss after immunization. JAMA 279 (1998) 117-118
46. Ascherio A., Zhang S., Hernan M., Olek M., Coplan P., Brodovicz K., et al. Hepatitis B vaccination and the risk of multiple sclerosis. N Engl J Med 344 (2001) 327-332
47. Confavreux C., Suissa S., Saddier P., Bourdes V., and Vukusic S. Vaccinations and the risk of relapse in multiple sclerosis. N Engl J Med 344 (2001) 319-326
48. Hernan M., Jick S., Olek M., and Jick H. Recombinant hepatitis B vaccine and the risk of multiple sclerosis; a prospective study. Neurology 63 (2004) 838-842
49. US Food and Drug Administration Web site. Statement: FDA and CDC update information on menactra meningococcal vaccine and Guillian-Barré syndrome date. www.fda.gov/cber/safety/gbs102006.htm [Accessed April 23, 2006
50. Centers for Disease Control and Prevention. Provisional ACIP recommendations: Use of zoster [shingles] vaccine. www.cdc.gov/nip/recs/provisional_recs/zoster-11-20-06.pdf [Accessed April 23, 2007]
51. Kimberlin D., and Whitley R. Varicella-zoster vaccine for the prevention of herpes zoster. N Engl J Med 356 (2007) 1338-1343
52. Zostavax package insert. Zoster vaccine live. Oka/Merck & Co. www.merck.com/product/usa/pi_circulars/z/zostavax/zostavax_pi.pdf [Accessed April 23, 2007]
53. Centers for Disease Control and Prevention. A new product (VarZIG) for postexposure prophylaxis of varicella available under an investigational new drug application expanded access protocol. MMWR Morb Mortal Wkly Rep 55 (2006) 209-210
54. Keitel W. Cellular and acellular pertussis vaccines in adults. Clin Infect Dis 28 suppl 2 (1999) S118-S123
55. Lee G., Murphy T., Lett S., Cortese M., Dretsinger K., Schauer S., et al. Cost effectiveness of pertussis vaccination in adults. Am J Prev Med 32 (2006) 186-193
56. Centers for Disease Control and Prevention. Prevention of tetanus, diphtheria and pertussis among pregnant women: Provisional ACIP recommendations for the use of Tdap vaccine. www.cdc.gov/nip/recs/provisional_recs/tdap-preg.pdf [Accessed April 23, 2007]
57. Centers for Disease Control and Prevention. A comprehensive immunization strategy to eliminate transmission of hepatitis B Virus infection in the United States. Recommendations of the Advisory Committee on Immunization Practices (ACIP) part 1: Immunization of infants, children and adolescents. MMWR Morb Mortal Wkly Rep 54 (2005) 1-39
58. Centers for Disease Control and Prevention. A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States. Recommendations of the Advisory Committee on Immunization Practices (ACIP) part II: Immunization of adults. MMWR Morb Mortal Wkly Rep 55 (2006) 1-25
59. Centers for Disease Control and Prevention. Hepatitis B virus: A comprehensive strategy for eliminating transmission in the United States through universal childhood vaccination: Recommendations of the Immunization Practices Advisory Committee (ACIP). MMWR Morb Mortal Wkly Rep 40 (1991) 1-19
60. Advisory Committee on Immunization Practices. Prevention and control of influenza: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 45 (1996) 1-24
61. Centers for Disease Control and Prevention. Influenza. In: Atkinson W., Hamborsky J., McIntyre L., and Wolfe S. (Eds). Epidemiology and prevention of vaccine-Preventable diseases (2004), Public Health Foundation, Waldorf, MD 213-231
62. Dodds L., McNeil S., Fell D., Allen V., Coombs A., Scott J., et al. Impact of influenza exposure on rates of hospital admissions and physician visits because of respiratory illness among pregnant women. CMAJ 176 (2007) 463-468
63. Hartert T., Neuzil K., Shintani A., Mitchel E., Snowden M., Wood L., et al. Maternal morbidity and perinatal outcomes among pregnant women with respiratory hospitalizations during the influenza season. Am J Obstet Gynecol 189 (2003) 1705-1712
64. Ayoub D., and Yazbak F. Delivering influenza vaccine to pregnant. Am J Epidemiol 165 (2007) 351-353
65. Centers for Disease Control and Prevention. Hepatitis A. In: Atkinson W., Hamborsky J., McIntyre L., and Wolfe S. (Eds). Epidemiology and prevention of vaccine-Preventable diseases. 10th ed. (2007), Public Health Foundation, Washington, DC
66. Centers for Disease Control and Prevention. Hepatitis B. In: Atkinson W., Hamborsky J., McIntyre L., and Wolfe S. (Eds). Epidemiology and prevention of vaccine-Preventable diseases. 10th ed. (2007), Public Health Foundation, Washington, DC
67. Centers for Disease Control and Prevention. Prevention and control of meningococcal disease. MMWR Morb Mortal Wkly Rep 54 (2005) 1-21
68. Centers for Disease Control and Prevention. Rubella. In: Atkinson W., Hamborsky J., McIntyre L., and Wolfe S. (Eds). Epidemiology and prevention of vaccine-Preventable diseases. 10th ed. (2007), Public Health Foundation, Washington, DC
69. Centers for Disease Control and Prevention. Tetanus. In: Atkinson W., Hamborsky J., McIntyre L., and Wolfe S. (Eds). Epidemiology and prevention of vaccine-Preventable diseases. 10th ed. (2007), Public Health Foundation, Washington, DC
70. World Health Organization Web site. Progress towards global elimination of MNT. www.who.int/immunization_monitoring/diseases/MNTE_initiative/en/index4.html [Accessed April 22, 2007]
71. PAHO/WHO. Reported cases of neonatal tetanus cases in the Americas, September 19, 2006. www.ops-oms.org/english/ad/fch/im/Nnt_NumberCases.pdf [Accessed April 22, 2007]
72. Intussusception among recipients of rotavirus vaccine-United States, 1998-1999. MMWR Morb Mortal Wkly Rep 48 (1999) 577-581
73. Withdrawal of rotavirus vaccine. MMWR Morb Mortal Wkly Rep 48 (1999) 1007
74. Institute of Medicine. Adverse events associated with childhood vaccines: Evidence bearing on causality (1994), National Academy Press, Washington, DC
75. Lee L., and Pichichero M. Costs of illness due to Bordeterlla pertussis in families. Arch Fam Med 9 (2000) 989-996
76. Davis M. Varicella vaccine, cost effectiveness analyses, and vaccination policy. JAMA 294 (2005) 845-846
77. Centers for Disease Control and Prevention. Notice to readers: Revised ACIP recommendations for avoiding pregnancy after receiving a rubella-containing vaccine. MMWR Morb Mortal Wkly Rep 50 (2001) 1117
78. US Food and Drug Administration Web site. Thimerosal in vaccines 2007. www.fda.gov/cber/vaccine/thimerosal.htm#pres [Accessed October 12, 2007]
79. Geier D., and Geier M. Neurodevelopmental disorders following thimerosal-containing childhood immunizations: A follow-up analysis. Int J Toxicol 23 (2004) 369-376
80. Schappert S., and Burt C. Ambulatory care visits to physician offices, hospital outpatient departments, and emergency departments: United States, 2001-2002. National Center for Health Statistics Vital Health Stat 13 (2006) 1-66